Edition:
India

People: Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

3.12USD
10:30pm IST
Change (% chg)

$-0.16 (-4.88%)
Prev Close
$3.28
Open
$3.27
Day's High
$3.31
Day's Low
$3.09
Volume
17,105
Avg. Vol
117,455
52-wk High
$7.44
52-wk Low
$1.90

Shreedhar, Vijay 

Mr. Vijay Shreedhar serves as Chief Commercial Officer of the Company. Prior to joining Adamas, Dr. Shreedhar served in a variety of sales and marketing roles of increasing responsibility in multiple therapeutic areas at Amgen, a biotechnology company, from August 2005 to May 2019. Most recently, he was Executive Director and Integrated Commercial Lead for the Multiple Myeloma franchise with responsibility for national sales, brand marketing and regional marketing teams. Dr. Shreedhar holds a Ph.D. in Oncology and Immunology from the University of Texas, M.D. Anderson Cancer Center and an MBA in Healthcare Management from the Wharton School at the University of Pennsylvania

Basic Compensation

Total Annual Compensation, USD 252,344
Restricted Stock Award, USD 321,063
Long-Term Incentive Plans, USD --
All Other, USD 656,687
Fiscal Year Total, USD 1,230,090

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Mahoney

264,876

Neil McFarlane

2,080,640

Christopher Prentiss

1,093,640

Adrian Quartel

--

Vijay Shreedhar

1,230,090

John MacPhee

67,705
As Of  31 Dec 2019